Dr. Giselle Saulnier Sholler, director of pediatric oncology research at Penn State College of Medicine and division chief of pediatric hematology and oncology at Penn State Health Golisano Children’s Hospital, began focusing on neuroblastoma after losing a patient early in her career. Neuroblastoma is an aggressive and cruelly resurgent cancer that mostly infects children under 6 years old. Dr. Sholler's mission is to change the outcomes, and she is accomplishing her goal by researching and receiving FDA approval for a drug called eflornithine (DFMO). Due to Penn State College of Medicine's commitment to research and the financial and research support from Four Diamonds, Dr. Sholler finds Penn State Health Golisano Children’s Hospital a perfect place to continue her mission and develop more clinical trials.
Childhood Cancer
Awareness Month
Is Here
See how our community is making an impact for kids battling cancer and how you can join the fight to conquer childhood cancer.
